Fuji Pharma Co., Ltd. (TYO:4554)
Japan flag Japan · Delayed Price · Currency is JPY
1,845.00
+7.00 (0.38%)
Aug 25, 2026, 3:30 PM JST

Fuji Pharma Cash Flow Statement

Millions JPY. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
4,0008,2764,3993,7233,371
Depreciation & Amortization
3,9653,6803,0232,7452,106
Loss (Gain) From Sale of Assets
394-4133
Loss (Gain) From Sale of Investments
--3,118---153
Other Operating Activities
-2,193-1,027-941-1,504-915
Change in Accounts Receivable
525-1,997-3,705-549-174
Change in Inventory
-3,0781,552-3,395-3,618-1,340
Change in Accounts Payable
356-1,640-6524472,038
Change in Other Net Operating Assets
1,832-1,5753,184-1,9031,027
Operating Cash Flow
5,8014,1511,917-6585,993
Operating Cash Flow Growth
39.75%116.54%--3.86%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Capital Expenditures
-1,981-2,778-3,327-5,097-3,789
Sale of Property, Plant & Equipment
22101,3831,673
Sale (Purchase) of Intangibles
-1,873-1,594-570-7,326-107
Investment in Securities
-5,356--189
Other Investing Activities
-367-2,644-1,353-231-311
Investing Cash Flow
-4,219-1,658-5,240-11,271-2,345

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Short-Term Debt Issued
-4,0003,0001,3006,000
Long-Term Debt Issued
9,987-2,9857,3001,000
Total Debt Issued
9,9874,0005,9858,6007,000
Long-Term Debt Repaid
-7,749-5,210-2,740-2,140-1,756
Total Debt Repaid
-7,749-5,210-2,740-2,140-1,756
Net Debt Issued (Repaid)
2,238-1,2103,2456,4605,244
Issuance of Common Stock
21055--11
Repurchase of Common Stock
-----9,405
Common Dividends Paid
-1,036-972-899-729-807
Other Financing Activities
-4581,692-431-637-478
Financing Cash Flow
954-4351,9155,094-5,435

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Foreign Exchange Rate Adjustments
123202185183-55
Miscellaneous Cash Flow Adjustments
1-2-1-
Net Cash Flow
2,6602,260-1,221-6,653-1,842

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
3,8201,373-1,410-5,7552,204
Free Cash Flow Growth
178.22%----36.08%
Free Cash Flow Margin
7.39%2.98%-3.45%-16.25%6.48%
Free Cash Flow Per Share
156.5456.48-58.02-236.9082.03
Levered Free Cash Flow
535.5599.13-4,258-11,7241,392
Unlevered Free Cash Flow
741.75721.63-4,182-11,6761,425

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
3271941048259
Cash Income Tax Paid
2,1971,0269461,498911
Change in Working Capital
-365-3,660-4,568-5,6231,551